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1. Introduction  
This chapter will examine the associations between Generalised Anxiety Disorder (GAD) 
and key health outcomes, including mortality, the metabolic syndrome, and hypertension, 
citing relevant research and recent findings from the Vietnam Experience Study. It aims to 
show that GAD is as strong a determinant of such health outcomes, if not a stronger one 
than MDD. It also aims to illustrate the importance of considering the comorbidity of GAD 
with other psychiatric diagnoses when predicting mortality and other health outcomes.  
2. GAD and mortality 
Mental health disorders in the general population are relatively common (Kessler et al., 
2005; Kessler, Chiu, Demler, Merikangas, & Walters, 2005). In fact, an estimated 14% of the 
global disease burden has been attributed to mental health disorders (World Health 
Organisation, 1992-1994), and this figure is likely to be an underestimate as it fails to take 
into consideration the association between mental health and other health conditions (Prince 
et al., 2007). Populations who have been exposed to traumatic events, such as war veterans, 
have an even higher prevalence of Generalised Anxiety Disorder (GAD) and Major 
Depressive Disorder (MDD) (Gaylord, 2006; Hoge, Auchterlonie, & Milliken, 2006; Reeves, 
Parker, & Konkle-Parker, 2005). For example, soldiers assessed a few months after returning 
from deployment to Afghanistan and Iraq had a GAD prevalence of around 14% and 15%, 
respectively, and prevalence of MDD of around 17% and 16% (Hoge et al., 2004). Others 
have reported depressive symptom rates as high as 19% in veterans based on prior 
diagnosis records (Kinder et al., 2008), and 31% using self-report measures (Hankin, Spiro, 
Miller, & Kazis, 1999), although some studies have shown lower rates of 6.9% and 1.7% for 
MDD and GAD, respectively (Sareen et al., 2007). Little has been reported about the 
consequences for survival of these mental health disorders in veterans.  
In the general population, MDD has been associated with increased mortality rates (see e.g. 
O'Leary & Lee, 1996; Surtees & Barkley, 1994). Although much of this excess is attributable 
to non-medical causes of death such as injury and suicide, it is becoming clear that MDD 
also increases the risk of death from common chronic diseases such as cardiovascular 
disease (CVD) (Osby, Brandt, Correia, Ekbom, & Sparen, 2001). There is now substantial 
evidence linking depression with CVD morbidity and mortality (see e.g. Musselman, Evans, 
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& Nemeroff, 1998; Wulsin, Vaillant, & Wells, 1999). However, much of this research has 
examined the impact of depressed mood rather than a diagnosis of MDD. In a recent meta-
analysis of 11 studies of coronary heart disease (CHD), MDD, which had been measured in 
only three studies, was a much stronger predictor of CHD outcomes than depressed mood 
(Rugulies, 2002). Few studies have examined GAD as a risk factor for all-cause mortality, 
although two population studies suggest that, for causes of death other than suicide, GAD 
does not present a significant risk (Holwerda et al., 2007; Murphy, Monson, Olivier, Sobol, & 
Leighton, 1987). However, other manifestations of anxiety have been associated with an 
increased risk of CVD morbidity and/or mortality (see e.g. Eaker, Sullivan, Kelly-Hayes, 
D'Agostino, & Benjamin, 2005; Haines, Imeson, & Meade, 1987; Weissman, Markowitz, 
Ouellette, Greenwald, & Kahn, 1990). It would appear that no studies have measured the 
relationship between diagnosed GAD and CVD mortality. 
The bulk of research examining the consequences of mental health disorders for chronic 
disease in veterans has concentrated on post-traumatic stress disorder (PTSD). For example, 
lifetime prevalence of PTSD was linked with an increased mortality rate (Boscarino, 2006a, 
2006b). In addition, PTSD in veterans has also been associated with cardiovascular, digestive, 
musculoskeletal, endocrine-nutritional-metabolic, nervous system, respiratory, and 
nonsexually transmitted infectious diseases (J.A. Boscarino, 1997),  chronic changes in 
immunity (Boscarino & Chang, 1999), and markers of inflammatory disorders (Boscarino, 
2004). However, there appear to be few studies examining the influence of other major mental 
health disorders on mortality risk in veterans. In a study of PTSD and MDD in veterans, MDD 
was related to increased mortality following adjustment for age, demographic variables, health 
behaviours, and medical co-morbidities (Kinder, et al., 2008). The association between GAD 
and mortality in veterans does not appear to have been studied.  
Given the reported high prevalence of GAD and MDD in army veterans and the significant 
prevalence of these disorders in the general population, their individual and combined 
impact merits research attention. Recently, it was possible to address this issue in the 
Vietnam Experience Study.  
2.1 The Vietnam experience study 
The Vietnam Experience Study is an epidemiological study commissioned by the US 
congress to investigate the health consequences of the military experiences of Vietnam 
veterans. The participants were male military personnel drawn from approximately five 
million US Vietnam-era army veterans whose service files were stored at the National 
Personnel Records Center (Vietnam Experience Study, 1987). The Centers for Disease 
Control, Atlanta, had access to U.S. Veteran Administration records and provided a fully 
anonymised dataset. Those who entered military service between January 1, 1965 and 
December 31, 1971; served only one term of enlistment; served at least 16 weeks of active 
duty; earned a military specialty other than “trainee” or “duty soldier”; at discharge from 
active duty had a military pay grade no higher than sergeant; and had not died during 
military duties were eligible for inclusion. On reviewing a random sample of 48 513 records, 
1355 were found to be incomplete, 28 577 did not meet study entry criteria and 268 men died 
during military duties, so the final cohort included 18,313 former military personnel. Of 
those included in the original cohort, 17,867 were considered to be alive on December 31st 
1983 and therefore eligible for active follow-up.  
Information pertaining to place of service, military rank, ethnicity, and cognitive ability 
scores from the Army General Technical Test (hereafter referred to as “IQ”) was extracted 
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from the military archives. Participants were designated as being Vietnam veterans if they 
had served at least one tour of duty in Vietnam, and as non-Vietnam veterans if they did 
not (this group included men who served one or more tours of duty in Korea, Germany or 
the US). The ethnic origin of the study members were classified as ‘white’, ‘black’,  or 
‘other’; the latter group comprising Hispanics, Asians, Pacific Islanders, American 
Indians, and Alaskan Natives.  
In 1985 these participants were invited to participate in a telephone interview. Telephone 
directories, credit bureau searches, driver’s license and motor vehicle registration records, 
city directories, local records and personal field visits were all utilized to locate the 
whereabouts of apparently surviving men. Of those traced (N = 16 349), an interview was 
not possible for reasons of incarceration (N = 63), physical or mental disability (N = 20), 
refusal (N = 949), death during the tracing process (N = 53), or ‘other’ (N = 6). This resulted 
in a sample of 15,288 men (85.6% of those alive on December 31st 1983) who participated in 
the 1985 telephone survey (Batty et al., 2008). During the telephone survey, enquiries were 
made about the study participants’ socio-economic characteristics, health behaviours, and 
health. Socio-economic position was measured using household income in midlife. 
Frequency of alcohol consumption was classified as number of units consumed per week. 
Smoking habits and marital status were ascertained using standard questions. Participants 
were also asked whether or not they had a range of somatic physician-diagnosed health 
problems which included hypertension, cancer, diabetes and coronary heart disease  (The 
Centers for Disease Control Vietnam Experience Study., 1988a, 1988b).  
In 1986, a random sample of telephone interview respondents (N=6443) were invited to attend 
a three day medical examination with orientation at a single facility in Albuquerque, New 
Mexico, for which travel expenses and a nominal stipend were met; 4462 attended (69.3% of 
those invited). The mean age at medical examination was 38.3 years (range: 31.1 to 49.0). Of 
those invited, medical examination was not possible for reasons of incarceration (N = 26), 
physical or mental disability (N = 10), refusal (N = 949), death before invitation (N = 10), or 
‘refusal’ (N = 372). The main reasons for refusing to participate at this stage of data collection 
were: work related, e.g. unable to get leave with pay; a lack of interest in the study, e.g. unable 
to see how it would benefit them; or personal, e.g. did not like to travel. The final number of 
participants with complete data after the medical examination was 4256. This group represents 
23.3% of persons originally enrolled in the study. Sampling in the study is shown in Figure 1, 
below. For the medical examination, all men were requested to fast from 19.00 the evening 
before medical testing. Following the drawing of blood the following morning, cholesterol 
level was ascertained using a Kodak Ektachem 700 autoanalyzer (The Centers for Disease 
Control Vietnam Experience Study., 1988a, 1988b). Serum glucose level was determined with a 
standard adaptation of the glucose oxidase-peroxidase-chromogen-coupled system for glucose 
determination in biologic fluids (The Centers for Disease Control Vietnam Experience Study., 
1988a, 1988b). Blood pressure, while seated, was measured twice in the right arm using a 
standard mercury sphygmomanometer; for the purposes of analyses, an average was 
computed. Height and weight, measured using standard protocols, were used to calculate 
body mass index (BMI) (kg/m2).  
2.1.1 Psychological morbidity 
Psychological morbidity was assessed using the Diagnostic Interview Schedule (version 3A) 
as administered by a trained psychological technician. The Diagnostic Interview Schedule is 
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Fig. 1. Sampling in the Vietnam Experience Study 
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a standardized questionnaire that is designed to assess the prevalence of certain psychiatric 
conditions according to the Diagnostic and Statistical Manual of Mental Disorders (version 
III) criteria of the American Psychiatric Association (APA, 1980; Robins, Helzer, & Cottler, 
1987). Study participants were considered positive for GAD and MDD if they reported a 
pattern of symptoms in the previous 12 months that satisfied full Diagnostic and Statistical 
Manual of Mental Disorders (version III) criteria. Characteristics of those with and without a 
diagnosis of GAD are shown in Table 1. 
 
 Generalised 
Anxiety 
Disorder 
(N = 411) 
No Generalised 
Anxiety 
Disorder 
(N = 3845) 
 
p 
 Mean SD Mean SD  
Standardised IQ score from enlistment 96.5 16.18 101.9 14.99 <.001 
Units of alcohol per week 10.6 22.87 6.7 13.15 <.001 
Age at medical examination (years) 38.0 2.65 38.4 2.50 .003 
Total cholesterol (mmol/l) 5.5 1.01 5.5 1.09 .42 
Blood glucose (mg/dL) 95.6 20.44 94.2 16.66 .10 
SBP (mmHg) 123.8 13.06 122.9 11.93 .17 
BMI (kg/m2)  25.9 3.70 25.9 4.12 .88 
 N (%) N (%) p 
Place of service                Ever in Vietnam 
                                             Other overseas  
                                                        US only 
267 (65) 
85 (21) 
59 (14) 
2082 (54) 
1010 (26) 
753 (20) 
<.001 
 
Ethnicity:                                           White 
                                                             Black 
                                                             Other    
311 (76) 
61 (15) 
39 (9) 
3179 (83) 
435 (11) 
231 (6) 
.001 
 
Household income in midlife     <$20,000
-$40,000
>$40,000
184 (45) 
171 (42) 
56 (13) 
1018 (26) 
1958 (51) 
869 (23) 
<.001 
Smoking Status:                      Non smoker
                                                     Ex smoker 
                                            Current smoker 
79 (19) 
90 (22) 
242 (59) 
1006 (26) 
1119 (29) 
1720 (45) 
<.001 
 
Marital Status:                                Married   
                Divorced/separated/widowed 
                                            Never married 
244 (59) 
116 (28) 
51 (12) 
2887 (75) 
651 (17) 
307 (8) 
<.001 
 
Physical Illness                                       No 
diabetes/hypertension/cancer or CHD     Yes 
335 (82) 
76 (18) 
3349 (87) 
496 (13) 
.002 
Table 1. Characteristics of those with and without a diagnosis of GAD 
2.1.2 Mortality status 
The vital status of men between army discharge and December 31st 1983 (the date the 
cohort was established) was ascertained by cross-checking against a variety of mortality 
databases supplied by the US army, the Veterans Administration (Beneficiary Identification 
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and Records Locator Subsystem), the Social Security Administration, the Internal Revenue 
Service, and the National Center for Health Statistics (National Death Index). Vital status 
post-medical exam continued to be ascertained until 31st December 2000 using the same 
mortality databases. Mortality due to major CVD was classified using the International 
Classification of Diseases (ICD) (World Health Organisation, 1992) codes: ICD-9: 390–
434,436–448, and ICD-10: I00–I78 which comprised: acute rheumatic fever; chronic 
rheumatic heart diseases; hypertensive diseases; ischaemic heart diseases; pulmonary heart 
disease and diseases of pulmonary circulation; other forms of heart disease; cerebrovascular 
diseases; diseases of arteries, arterioles and capillaries. The CVD mortality variable thus 
encompasses death from a variety of disorders. 
2.2 Characteristics of those with GAD and who were deceased 
Of the 4256 participants, 9.7% for GAD and 6.5% met diagnostic criteria for MDD. GAD was 
significantly associated with serving in Vietnam, younger age at the time of the medical 
examination, being non-white, and equally likely to be divorced/separated/widowed as 
never married. These individuals also had lower IQ scores, and lower household income in 
mid life. Finally, they were more likely to be a current smoker and to drink more units of 
alcohol per week; and were more likely to have a physical illness. During the 15 years of 
follow-up there were 236 deaths. Higher mortality was associated with service in Vietnam, 
not being married, being non-white, having lower household income in midlife, higher 
blood pressure and blood glucose level, smoking; higher alcohol consumption, and reported 
physical illness at examination. The characteristics of those who were and were not 
deceased are shown in Table 2. 
2.3 Associations with mortality 
Following adjustment for age and the other covariates measured, described above in section 
2.1 and shown in Table 1, it was found that both those with GAD and those with MDD were 
at an increased risk of death during follow-up. This risk of all-cause mortality was roughly 
1.6 times greater than that of those with no diagnosis. However, the effect for GAD was 
stronger than that for MDD. In analyses using cardiovascular disease mortality as the 
outcome, adjusting for confounding variables, neither GAD nor MDD were related 
increased risk of death, although the associations were in the same direction as for all-cause 
mortality. 
Interestingly, 153 (3.6%) of participants had a diagnosis of both MDD and GAD in the past 
year. In fully adjusted analyses, simultaneously using comorbidity as a predictor variable as 
well as MDD or GAD alone, only comorbidity was significantly related to both all-cause and 
cardiovascular disease mortality. These differences between the diagnoses groups and risk 
of death are shown in Figure 2. 
The prevalence of GAD and MDD are higher than general population estimates (Kessler, 
Chiu, et al., 2005). However, even higher prevalence has been observed in other veteran 
groups when mental disorders were measured more proximally to combat exposure (Hoge, 
et al., 2004). Undoubtedly the most compelling and robust associations with mortality, both 
all-cause and CVD, emerged for MDD and GAD comorbidity. The present results regarding 
GAD contrast with those from the two previous studies on GAD and all-cause mortality, 
which suggest that GAD does not present a significant risk (Holwerda, et al., 2007; Murphy, 
et al., 1987). However, this discrepancy might be due to the difference in populations 
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 Died: All-cause 
(N = 236) 
Surviving 
(N = 4020) 
p 
 
 Mean SD Mean SD  
Standardised IQ score from enlistment 96.5 15.2 101.6 15.14 < .001 
Units of alcohol per week 11.9 23.00 6.8 13.7 < .001 
Age at medical examination (years) 38.6 2.68 38.3 2.51 .15 
Total cholesterol (mmol/l) 5.6 1.35 5.5 1.06 .45 
Blood glucose (mg/dL) 102.6 40.75 93.8 14.38 < .001 
SBP (mmHg) 125.4 15.65 122.9 11.79 .001 
BMI (kg/m2)  25.9 3.69 26.2 4.50 .20 
 N (%) N (%) p 
Place of service               Ever in Vietnam 
                                            Other overseas 
                                                       US only 
148 (63) 
49 (21) 
39 (17) 
2201 (55) 
1046 (26) 
773 (19) 
.06 
 
Ethnicity:                                           White 
                                                           Black 
                                                            Other    
162 (69) 
51 (21) 
23 (10) 
3328 (83) 
445 (11) 
247 (6) 
< .001 
 
Household income in midlife   <$20,000 
                                                      -$40,000 
                                                     >$40,000 
110 (47) 
105 (44) 
21 (9) 
1092 (27) 
2024 (50) 
904 (23) 
<.001 
Smoking Status:                     Non 
smoker 
                                                  Ex smoker 
                                         Current smoker 
42 (18) 
44 (19) 
150 (64) 
1043 (26) 
1165 (29) 
1812 (45) 
< .001 
 
Marital Status:                              Married 
               Divorced/separated/widowed 
                                            Never married 
129 (55) 
71 (30) 
36 (15) 
3002 (75) 
696 (17) 
322 (8) 
< .001 
 
Physical Illness                                      No 
diabetes/hypertension/cancer or CHD    Yes    
62 (26) 
174 (74) 
3510 (87) 
510 (13) 
< .001 
Table 2. Characteristics of those who were and were not deceased 
examined: older adults (Holwerda, et al., 2007) and the general population (Murphy, et al., 
1987). It is also possible that anxiety may only predict mortality in men, as in one previous 
study where an association between anxiety disorders and mortality was found for men but 
not women (van Hout et al., 2004). GAD has not been previously studied in terms of CVD 
mortality in the general population, or in the context of mortality per se in veterans. This 
seems unfortunate given that it is a strong predictor of all-cause mortality in the present 
analyses. The present findings are consistent with the results of previous research linking 
MDD with all-cause mortality in the general population (e.g. O'Leary & Lee, 1996; Surtees & 
Barkley, 1994) and in veterans (Kinder, et al., 2008). Although many studies have considered 
depression as a predictor of CVD mortality, surprisingly few have examined diagnosed 
MDD. Of those available, both positive (Osby, et al., 2001) and null (Hallstrom, Lapidus, 
Bengtsson, & Edstrom, 1986; Vogt, Pope, Mullooly, & Hollis, 1994) findings have been 
reported. Although little attention has been paid to MDD and all-cause mortality in 
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veterans, our findings are consistent with those of one recent study in which individuals 
with a diagnosis of depression were at increased risk of death over an average of two years 
(Kinder, et al., 2008).  
Some studies have examined the prognostic importance of both symptoms of anxiety and 
depression and mortality in cardiac patient groups. In a review of 25 studies of chronic heart 
failure patients, anxiety symptoms were measured along with depression in just three 
studies (Pelle, Gidron, Szabo, & Denollet, 2008). Anxiety symptoms were not associated 
with mortality, whereas depressive symptoms significantly predicted death (Pelle, et al., 
2008). A number of studies have examined both anxiety and depression symptoms and 
mortality in myocardial infarction patients. High depression and anxiety scores have both 
been found to predict all-cause mortality (Herrmann et al., 1998), and cardiac death 
(Denollet & Brutsaert, 1998). However, in three studies, symptoms of depression but not 
anxiety in multivariate models predicted all-cause or cardiac mortality (Ahern et al., 1990; 
Frasure-Smith & Lesperance, 2003; Frasure-Smith, Lesperance, & Talajic, 1995). Finally, 
neither depression nor anxiety symptoms were found to predict mortality in myocardial 
infarction patients (Lane, Carroll, Ring, Beevers, & Lip, 2001). Thus, in prognostic studies, it 
would appear that depressive symptoms may be a more stable predictor of mortality than 
anxiety. However, it is unclear the extent to which the results of these studies of patients 
with chronic inflammatory disease relate to the present aetiological study where only 1% 
had a diagnosis of coronary heart disease at the medical examination. It is possible that the 
effects of depression on mortality and the underlying mechanisms may not be identical in 
patient versus population-based studies. Further, none of the prognostic studies that we 
know of have examined psychiatric comorbidity effects on mortality.  
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Fig. 2. Percentage deceased in each diagnosis category 
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GAD and MDD are highly comorbid psychiatric conditions (Kessler, Chiu, et al., 2005). In 
the present study, 3.6% of participants had a diagnosis of both MDD and GAD. More 
strikingly, 55% of those with a diagnosis of MDD also had GAD. Patients with comorbid 
MDD and GAD have been found to have poorer functional status than those with either 
condition alone (Kessler, DuPont, Berglund, & Wittchen, 1999) and it has been proposed 
that they are at increased risk for CVD (Sevincok, Buyukozturk, & Dereboy, 2001). However, 
we know of no previous studies that have examined the mortality risk associated with this 
comorbidity. The present analysis indicates that comorbid MDD and GAD confers a 
stronger mortality risk than either condition alone. The importance of comorbidity was 
further demonstrated in the supplementary analyses of the effects of comorbidity with 
PTSD where it was the comorbidity of MDD and GAD, and of PTSD, MDD, and GAD that 
emerged as the most consistent predictors of mortality. Consequently, this argues that 
comorbidity should receive considerably more attention in future research on mental 
disorders and health outcomes, at least in studies of non-patient groups. Further, clinical 
interventions have tended to concentrate on single mental health diagnoses; these findings 
suggest that targeting comorbidity might be a fruitful new approach. 
2.4 Limitations 
It should be conceded that there are a number of limitations to this analysis and its 
interpretation. First, the weaker effects for CVD in comparison to all-cause mortality may 
reflect the small number of deaths due to CVD in this sample resulting in lower power to 
detect significant associations, particularly when adjusting for a large number of covariates. 
Support for this assertion can be found in the hazard ratios which were of comparable size 
in the fully adjusted models for both all-cause and CVD mortality, but only attained 
significance when all-cause mortality was the outcome. Second, residual confounding as a 
consequence of un-measured variables cannot be wholly discounted. The present analysis, 
however, did adjust for a large number of potential confounding variables. Third, as this 
sample was exclusively male, there is the issue of generalisation. It should be noted that the 
previous studies with null results tested women only in one case (Hallstrom et al., 1986) and 
both sexes in the other (Vogt et al., 1994). It is also worth noting, though, that these studies had 
much smaller samples, reducing their power to detect effects on mortality. In addition, it is 
possible that veterans differ in other ways from the broader population. For example, one 
study of stable coronary heart disease that included veterans found no evidence that 
depression was associated with elevated levels of inflammation (Whooley et al., 2007); a 
finding opposite to that of many studies in non-cardiac disease patients. However, not all the 
patients in this study were veterans (Whooley et al., 2007). Fourth, it has been suggested that 
the prevalence of mental health disorders in the Vietnam Experience Study are 
underestimated (Dohrenwend et al., 2006, 2007). However, this criticism has mainly been 
levelled at estimations of PTSD prevalence. Nevertheless, it is possible that severely depressed 
veterans were less likely to participate in the medical examination, which may have accounted 
for the attenuated associations for major depression in the present analyses. However, this 
seems unlikely given that only 10 (<2%) veterans were unable to attend on the basis of 
physical/mental disability, and only 372 (<6%) refused to attend, with the main reasons being 
a lack of interest or unwillingness to travel. Moreover, underestimation in the present study 
would make the associations demonstrated between MDD, GAD, their comorbidity and 
mortality more compelling. Fifth, given that a diagnosis of MDD only requires two weeks of 
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symptoms, whereas GAD requires symptoms for at least six months, it is possible that MDD 
diagnoses were less trustworthy. However, evidence indicates that the DSM-III criteria for 
diagnosis of both MDD and GAD are highly reliable (Riskind et al., 1987).  
In conclusion, the present analysis in Vietnam veterans showed that MDD and GAD were 
positively associated with all-cause and CVD mortality. However, in the fully adjusted 
analyses reported, the relationships with CVD mortality were non-significant, possibly due 
to low statistical power.  A diagnosis of both MDD and GAD proved much the strongest 
predictor of all-cause and CVD mortality. The effects of comorbidity of MDD and GAD, and 
with PTSD would suggest that future research on mental health disorders and physical 
health outcomes, as well as future clinical interventions, should pay more attention to 
comorbidity. In addition, future studies should attempt to measure and take account of a 
full range of factors likely to be associated with both mental and physical health.  
3. GAD and the metabolic syndrome 
The metabolic syndrome (MetS) is a prevalent cluster of symptoms (obesity, high 
triglyceride levels, low levels of HDL cholesterol, raised blood pressure, and high levels of 
fasting blood glucose or a diagnosis of diabetes) (Isomaa et al., 2001; Lakka et al., 2002; 
Thomas et al., 2007; Trevisan, Liu, Bahsas, & Menotti, 1998). As the metabolic syndrome 
increases risk for cardiovascular and all-cause mortality (Isomaa, et al., 2001; Lakka, et al., 
2002; Thomas, et al., 2007; Trevisan, et al., 1998), recently there has been interest in the 
relationship between it and various mental health disorders.  
The bulk of this research has focused on depression and although contrary indications exist 
(Herva et al., 2006), there is evidence of a positive association between depression and the 
metabolic syndrome (Dunbar et al., 2008; Heiskanen et al., 2006; Kinder, Carnethon, 
Palaniappan, King, & Fortmann, 2004; Koponen, Jokelainen, Keinanen-Kiukaanniemi, 
Kumpusalo, & Vanhala, 2008; McCaffery, Niaura, Todaro, Swan, & Carmelli, 2003; 
Raikkonen, Matthews, & Kuller, 2002; Skilton, Moulin, Terra, & Bonnet, 2007; Vaccarino et 
al., 2008). However, the vast majority of these studies were concerned with depressive 
symptoms; a recent review (Goldbacher & Matthews, 2007) identified only two studies 
examining MDD in this context. In a small study of outpatients, those who still had a 
diagnosis at 6-year follow-up showed a higher prevalence of the metabolic syndrome 
(Heiskanen, et al., 2006). In a larger scale study, a history of MDD was associated with the 
metabolic syndrome in women but not men (Kinder, et al., 2004). Much less attention has 
been paid to anxiety and the metabolic syndrome and the three most recent studies 
reported null findings (Herva, et al., 2006; Raikkonen, Matthews, & Kuller, 2007; Skilton, 
et al., 2007). However, an earlier study of women found an association between the 
metabolic syndrome and increased anxiety seven years later (Raikkonen, et al., 2002). 
These studies have all been concerned with anxiety symptoms; no study has tested the 
association with GAD. We were able to utilise the Vietnam Experience Study dataset in 
order to examine the potential links between GAD and the metabolic syndrome. In this 
dataset, the metabolic syndrome was defined as having at least three of: BMI > 30 kg/m2 
(in the absence of waist circumference data, BMI at this threshold is regarded by World 
Health Organization as an acceptable substitute in defining MetS); triglycerides ≥ 1.7 
mmol/l (150 mg/dl); HDL cholesterol < 1.036 mmol/l (40 mg/dl); blood pressure ≥ 
130/85 mmHg or taking antihypertensive medication; fasting glucose ≥ 6.1 mmol/l (110 
mg/dl) or taking diabetes medication.  
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3.1 Associations with the metabolic syndrome 
Seven hundred and seventy-three (18%) of the men in the Vietnam Experience Study were 
identified as having the metabolic syndrome. Aside from differing on all the components of 
the metabolic syndrome, participants with it were slightly older, had lower IQ scores and a 
briefer education, were less likely to be divorced, widowed or separated and more likely to 
come from ethnic groups other than white or black, i.e. Hispanic. Full details of the 
characteristics of those with and without the metabolic syndrome are shown in Table 3.  
 
 Metabolic syndrome 
(N = 773) 
No metabolic syndrome 
(N = 3483) 
p 
 
 Mean SD Mean SD  
Metabolic Syndrome Markers:      
BMI (kg/m2)  30.00 4.16 25.03 2.96 <.001 
Triglycerides (mg/dL) 214.20 151.22 91.97 56.70 <.001 
HDL cholesterol (mg/dL) 34.85 7.78 46.85 12.24 <.001 
SBP (mmHg) 131.46 11.87 121.13 11.25 <.001 
DBP (mmHg) 91.16 8.64 82.56 8.88 <.001 
Blood glucose (mg/dL) 104.57 28.06 92.04 12.35 <.001 
Covariates:      
Age at medical examination (years) 38.67 2.51 38.25 2.51 <.001 
Units of alcohol per week 6.69 15.46 7.17 14.18  .40 
Standardised IQ score from enlistment  99.63 15.03 101.75 15.20 <.001 
Grade achieved in education 13.04 2.26 13.35 2.31  .001 
 N (%) N (%) p 
Metabolic Syndrome Markers:    
Obese 396 (51) 154 (4) <.001 
Hypertension Diagnosis                 189 (24) 252 (7) <.001 
Diabetes Diagnosis                                27 (4) 22 (1) <.001 
Predictor variables:    
MDD 57 (7) 220 (6) .28 
GAD 94 (12) 317 (9) .009 
Covariates:    
Place of service                Ever in Vietnam
                  Other overseas
                                            US only
444 (63) 
195 (21) 
134 (17) 
1905 (55) 
900 (26) 
678 (19) 
.29 
 
Ethnicity:                                            White
                                             Black
                                                   Other 
633 (82) 
74 (10) 
66 (8) 
2857 (82) 
422 (12) 
204 (6) 
 .005 
 
Household income in midlife     <$20,000
                                          -$40,000
                                                      >$40,000
234 (30) 
380 (49) 
159 (21) 
968 (28) 
1749 (50) 
766 (22) 
.35 
Smoking Status:                     Non smoker
                                                     Ex smoker
                               Current smoker
194 (25) 
226 (29) 
353 (46) 
891 (26) 
983 (28) 
1609 (46) 
.85 
 
Marital Status:                                Married
                Divorced/separated/widowed
                                   Never married
612 (79) 
99 (13) 
62 (8) 
2519 (72) 
668 (19) 
296 (9) 
< .001 
 
Table 3. Characteristics of those with and without the metabolic syndrome 
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In this sample, MDD was not significantly associated with the metabolic syndrome in either 
age-adjusted analyses or those adjusting for other confounding variables described above. 
However, there was a positive association between GAD and the metabolic syndrome, such 
that those with GAD were 1.36 times more likely to have the metabolic syndrome than those 
without GAD diagnosis. Depression and anxiety are highly co-morbid conditions, and in the 
present sample, MDD and GAD were significantly correlated, C(1) = .38, p < .001, and 153 
(4%) were diagnosed with both conditions. Consequently, in competitive models, entering 
MMD alone, GAD alone, and their co-morbidity simultaneously, only GAD was associated 
with metabolic syndrome incidence.  
These findings contrast with the results of previous studies, however, these have been 
concerned with symptoms of anxiety and the analysis reported above is the first to examine 
GAD in the context of the metabolic syndrome. Further, only two studies, to date, have 
explored the links between MDD and the metabolic syndrome (5,7). The much larger of 
these two studies reported an association with MDD in women, but not men (Kinder, et al., 
2004). Thus, the apparent discrepancy between the present findings and those of others may 
be more illusory than real. Of the components of the metabolic syndrome, it was 
hypertension, obesity, and triglycerides that differentiated those with and without GAD. 
There was no association with diabetes.  
3.2 Limitations and potential mechanisms 
Unfortunately, with cross-sectional analyses it is impossible to determine the direction of the 
association and whether it is causal. If anxiety precedes metabolic syndrome, there are at 
least two pathways through which it might contribute to its aetiology. First, anxiety has 
been associated with unhealthy behaviour, such as smoking, binge drinking, physical 
inactivity, and unhealthy diet (Strine et al., 2008). However, despite the fact that participants 
with GAD consumed more units of alcohol per week and were more likely to be current 
smokers, the present association between GAD and metabolic syndrome was unaffected by 
adjustment for smoking and alcohol consumption. Second, it has been postulated that 
hypothalamic-pituitary-adrenocortical dysregulation associated with affective disorders, 
including anxiety, may contribute over time to the metabolic syndrome (Raikkonen, et al., 
2002). There is evidence linking anxiety with altered cortisol activity; high levels of anxiety 
symptoms were found to be associated with a less pronounced cortisol awakening response 
(Therrien et al., 2008). However, it remains possible that the causal pathway is from the 
metabolic syndrome to GAD. The metabolic syndrome has been shown to predict symptoms 
of anxiety seven years later (Raikkonen, et al., 2002), whereas the reverse was not found 
(Raikkonen, et al., 2002, 2007). Further, it is reasonable to presume that diagnosis of some of 
the components of the metabolic syndrome may be anxiolytic. For example, irrespective of 
actual blood pressure levels, perceived hypertensive status was positively associated with 
anxiety (Spruill et al., 2007). Whatever the underlying mechanism of the association with 
GAD, it remains true that depression has been the main focus for studies of mental health 
and physical health outcomes. The current data suggest that future research should perhaps 
pay equal attention to GAD.  
The present analyses may have other limitations. The generalisability of the sample, being 
wholly male was raised above. A recent review concluded that evidence relating depression 
to the metabolic syndrome was stronger for women than men (Goldbacher & Matthews, 
2007). Our failure to find an association for depression might also reflect lower power, since 
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there were fewer participants with MDD than GAD, as discussed above. Finally, although 
we adjusted for many possible confounders, residual confounding as a consequence of 
poorly measured or unmeasured variables cannot be wholly discounted. For example, both 
GAD and MetS are associated with poor sleep quality (Tyrer & Baldwin, 2006; Jennings et 
al., 2007). Future studies should not only pay more attention to GAD as a serious predictor 
of health outcomes, but also take into account health behaviours such as sleep quality. 
4. GAD and hypertension 
Despite the health risks associated with hypertension (Chiong, 2008), few studies have 
examined whether mental health disorders can contribute to hypertension risk. Nothing is 
known about the association between GAD and hypertension, although three studies have 
examined the association between hypertension and symptoms of anxiety. Whereas the 
National Health and Nutrition Examination Survey (NHANES) (Jonas, Franks, & Ingram, 
1997) and the Framingham study (Markovitz, Matthews, Kannel, Cobb, & D'Agostino, 1993) 
both observed a positive prospective association between symptoms of anxiety and 
hypertension, the Coronary Artery Risk Development in Young Adults (CARDIA) study 
reported no consistent relationship between the two (Yan et al., 2003). However, the 
measures of anxiety used in these studies were not synonymous with a clinical diagnosis of 
GAD. Similarly, few studies have examined the relationship between MDD and 
hypertension. However, there is at least some cross-sectional and prospective evidence of a 
positive association (Patten et al., 2005; Patten et al., 2009). GAD and MDD are highly co-
morbid, and as outlined above, both GAD and its co-morbidity with MDD predicted both 
all-cause and cardiovascular disease mortality, and GAD was also related to metabolic 
syndrome incidence. Using the Vietnam Experience Study again, it was hypothesised that 
both GAD and MDD would be linked to hypertension. It was also hypothesised that 
hypertension would be particularly prevalent among those with co-morbid MDD and GAD. 
At the medical examination in 1986, with the participant in a sitting position, a registered 
nurse, using a standard mercury sphygmomanometer to blood pressure measured, twice 
consecutively, from both arms. For analysis, an average of the two right arm values was 
computed. Measurements from the left arm were used to verify individual results. 
Hypertension was defined by having one of the following: a reported physician-diagnosis at 
interview; reported taking antihypertensive medication; an average systolic blood pressure 
≥ 140 mmHg; an average diastolic blood pressure ≥ 90 mmHg at the medical examination. 
There were 441 participants who indicated during the telephone interview that they had a 
physician diagnosis of hypertension and a further 98 who, although not reporting a 
diagnosis of hypertension, indicated that they were taking antihypertensive medication. 
Others have encountered individuals without an acknowledged diagnosis of hypertension 
who report taking antihypertensive medication and have designated them as hypertensive 
(Patten et al., 2009). The remainder and majority (N = 842) of those classified as hypertensive 
was as a result of the blood pressure assessment at the medical examination. This suggests 
that there was substantial undiagnosed and/or untreated hypertension. As our outcome 
measure is hypertension, it is essential to include participants with a physician diagnosis of 
hypertension in that outcome. Of the participants with a diagnosis of hypertension, 292 
(66%) were taking anti-hypertensive medication. The effect of this would be to lower blood 
pressure, such that some of these participants (N = 108) no longer met a criterion solely 
based on measured blood pressure. Nevertheless, they are still rightly regarded as suffering 
from hypertension.  
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4.1 Associations with hypertension 
One thousand, three hundred, and eighty-one (33%) of the veterans were classified as 
hypertensive. Veterans who were older, black, had served in Vietnam, were non smokers, 
had a relatively high BMI, and consumed more units of alcohol per week, and had lower 
household income in midlife were more likely to be hypertensive. The characteristics of 
those with and without hypertension are shown in Table 4. 
 
 Hypertensive 
(N = 1381) 
Normotensive 
(N = 2801) 
p 
 Mean SD Mean SD  
SBP (mmHg) 132.80 12.01 118.07 8.69 <.001 
DBP (mmHg) 93.42 8.19 79.40 6.05 <.001 
Age at medical examination (years) 38.57 2.48 38.20 2.54 <.001 
BMI (kg/m2)  27.64 4.28 25.07 3.13 <.001 
Alcohol consumption (units/week) 8.89 18.42 6.26 12.03 <.001 
 N (%) N (%) p 
Place of service                Ever in Vietnam
                                             Other overseas
                                                         US only
818 (59) 
342 (25) 
221 (16) 
1491 (53) 
732 (26) 
578 (21) 
<.001 
 Ethnicity                                            White
                                                              Black
                                                              Other 
1056 (76) 
236 (17) 
89 (7) 
2375 (85) 
252 (9) 
174 (6) 
<.001 
Education grade                                   ≤ 11
                                                                = 12
                                                                < 12
179 (13) 
529 (38) 
673 (49) 
326 (12) 
1007 (36) 
1468 (52) 
.08 
Household income in midlife    <$20,000
                                                          -$40,000
                                                      >$40,000
428 (31) 
676 (49) 
277 (20) 
752 (27) 
1420 (51) 
629 (22) 
.01 
Smoking status                       Non smoker
                                                     Ex smoker
                                          Current smoker
393 (28) 
400 (29) 
588 (43) 
670 (24) 
793 (28) 
1338 (48) 
.001 
 
Marital Status:                             Married
                Divorced/separated/widowed
                                       Never married
991 (72) 
257 (19) 
133 (9) 
2083 (74) 
498 (18) 
220 (8) 
.10 
 
Predictor Variables:    
GAD 171 (12) 232 (8) <.001 
MDD 121 (9) 155 (6) <.001 
Table 4. Characteristics of those with and without hypertension 
Both GAD and MDD were associated with an elevated risk of hypertension in fully-adjusted 
models, although the association was stronger for MDD than GAD on this occasion. Of the 
participants with co-morbid GAD and MDD, 72 (47%) were hypertensive. Both GAD, MDD, 
and comorbidity were associated with an increased risk of hypertension in age-adjusted 
analyses, but when adjusting for all other covariates, only comorbidity was significantly 
related to hypertension, although there was a trend for a relationship with GAD (p = .06).  
Given that antihypertensive medication can be prescribed for conditions other than 
hypertension, hypertension was redefined based on only physician diagnosis and 
measured blood pressure. This reduced the sample to 4180 and the numbers classified as 
hypertensive as 1329 (32%). In the separate fully adjusted models, both GAD and MDD 
were positively associated with hypertension defined in this alternative fashion. 
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However, in the fully adjusted comorbidity competitive analysis, no statistically 
significant relationships emerged. The only association to approach significance was 
between co-morbidity and hypertension. 
Over 30% of the sample met the main criteria for hypertension. This proportion is somewhat 
higher than that reported from studies with participants of a similar mean age (e.g., Patten, 
et al., 2009). However, in part this could reflect different definitions of hypertension; relying 
solely on reported diagnostic and medication status, and not including measured blood 
pressure, will almost certainly lead to an underestimate of prevalence. In addition, the 
present sample was clustered at the low end of the socio-economic spectrum. This might 
also help explain their relatively high prevalence of hypertension. Other analyses indicate an 
inverse gradient between socio-economic status and measured blood pressure, although a 
less consistent association between socio-economic position and hypertension treatment 
rates (Colhoun, Hemingway, & Poulter, 1998). In the present sample, however, household 
income in midlife was associated with hypertension. 
Both GAD and MDD were positively associated with hypertension. The latter result is 
consistent with the cross-sectional and prospective outcomes from the Canadian National 
Population Health Survey (Patten et al., 2005; Patten, et al., 2009). We know of no previous 
studies that have examined the relationship between GAD and hypertension. However, a 
positive association between symptoms of anxiety and hypertension has been reported from 
NHANES and the Framingham study (Jonas, et al., 1997; Markovitz, et al., 1993), although 
no such relationship emerged from analysis of data from the CARDIA study (Yan, et al., 
2003). In fully adjusted competitive analysis, we found that only the co-morbidity of GAD 
and MDD was significantly associated with an increased risk of hypertension. It is possible 
that co-morbidity signals more severe psychiatric dysfunction and that it is the severity of 
dysfunction that is associated with physical health outcomes, similar to the findings for 
mortality above. However, it is also possible that comorbidity reflects a greater negative 
disposition, and it is this which is associated with hypertension (Suls & Bunde, 2005). 
Whatever the case, given the high comorbidity of GAD and MDD, it is perhaps regrettable 
that studies of psychiatric disorders and physical health have focused almost exclusively on 
single disorders.  
4.2 Limitations and mechanisms 
Although we are not able to determine causality from the present cross-sectional 
associations, the prospective associations between MDD and hypertension (Patten et al., 
2009) and symptoms of anxiety and hypertension studies (Jonas et al., 1997; Markovitz et al., 
1993), cited above, make it unlikely that GAD or MDD are a psychological response to 
hypertension diagnosis. There are several putative pathways through which disorders such 
as GAD and MDD might contribute to development of hypertension. In addition, in the 
majority of instances in the present study, hypertension was apparently undiagnosed. 
Further, many of the sample had served in Vietnam. As a life event, a diagnosis of 
hypertension is likely to pale by comparison. The two most cited are unhealthy behaviours 
and physiological dysregulation. In the present analyses, the associations were still 
evident following adjustment for two of the most prominent unhealthy behaviours, 
smoking and high levels of alcohol consumption. That smokers have lower blood pressure 
and that alcohol consumption is positively related to hypertension are common 
observations (Beilin, 1987; Green, Jucha, & Luz, 1986). Although we have no data directly 
pertaining to the second route, others have observed altered activity of the hypothalamic-
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pituitary-adrenal axis in approximately 50% of depressed patients (Brown, Varghese, & 
McEwen, 2004), which, in turn, may increase the risk of hypertension (Torpy, Mullen, 
Ilias, & Nieman, 2002).  
Other limitations of this analysis are that, as discussed above, the present study’s 
participants were all men and so there is the issue of generalisation. Indeed, in the 
Framingham study, symptoms of anxiety predicted hypertension in middle-aged men but 
not middle-aged women (Markovitz et al., 1993). Accordingly, the associations reported 
here may pertain only for men. In addition, the present participants were largely from the 
lower end of the socio-economic spectrum and thus our findings may not generalise to the 
population as a whole. However, these analyses again indicate the importance of GAD, as 
well as MDD in terms of health outcomes, and particular their comorbidity.  
5. Conclusion 
In conclusion, the analyses discussed above indicated that both GAD and MDD were 
individually positively related to all-cause mortality and to hypertension in male Vietnam-
era veterans. However, the strongest association with both mortality and hypertension was 
observed for co-morbid GAD and MDD. Further, when considering another major health 
outcome, the metabolic syndrome, GAD but not MDD was associated with an increased 
prevalence of this constellation of symptoms. Depression has been the main focus for 
studies of psychiatric disorders and physical health outcomes. The current data suggest that 
future research should perhaps pay equal attention to GAD and, for some outcomes, it 
seems that it is particularly its co-morbidity with MDD and/or other mental disorders 
which might predict poorer health.  Future research remains to determine the mechanisms 
underlying these associations with health outcomes, through prospective assessment and a 
thorough inclusion of both biological and behavioural covariates. 
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